FRACTIONATION AND CHARACTERIZATION OF AN INHIBITOR OF PLASMIN FOUND IN NORMAL PLASMA.

[1]  P. S. Roberts.  The esterase activities of human plasmin during purification and subsequent activation by streptokinase or glycerol. , 1960, The Journal of biological chemistry.

[2]  J. Hagan,et al.  Purification and biochemical properties of human plasminogen. , 1960, The Journal of biological chemistry.

[3]  A. Fletcher,et al.  Studies on enhanced fibrinolytic activity in man. , 1959, The Journal of clinical investigation.

[4]  P. Norman,et al.  Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma. , 1958 .

[5]  P. Norman.  STUDIES OF THE PLASMIN SYSTEM : II. INHIBITION OF PLASMIN BY SERUM OR PLASMA , 1958 .

[6]  J. Farquhar,et al.  Response of Serum Lipids and Lipoproteins of Man to Beta‐Sitosterol and Safflower Oil: A Long‐Term Study , 1958, Circulation.

[7]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[8]  M. Morales.  If an Enzyme-Substrate Modifier System Exhibits Non-competitive Interaction, then, in General, its Michaelis Constant is an Equilibrium Constant , 1955 .

[9]  S. Sherry,et al.  The activation of human plasminogen by streptokinase. , 1955, The Journal of biological chemistry.

[10]  D. Kline.  The purification and crystallization of plasminogen (profibrinolysin). , 1953, The Journal of biological chemistry.

[11]  G. Scatchard,et al.  Physical-chemical characteristics of certain of the proteins of normal human plasma. , 1947, The Journal of physical and colloid chemistry.

[12]  J. B. Duguid.  Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. , 1946, The Journal of pathology and bacteriology.